Effectiveness of GnRH antagonist in intrauterine insemination cycles

Mohan S. Kamath, R. Ramya, Ramya R, Priya Bhave, Muthukumar K, K. Muthukumar, Aleyamma TK, Aleyamma T K, Korula George
European journal of obstetrics, gynecology, and reproductive biology · 2012 · vol. 166(2) , pp. 168–172 · doi:10.1016/j.ejogrb.2012.09.023 · PMID:23083636 · W2068185844
RCT OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study evaluated the effectiveness of GnRH antagonist use in intrauterine insemination cycles.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To evaluate the effectiveness of GnRH antagonists in women undergoing controlled ovarian stimulation and intrauterine insemination cycles (COS/IUI). STUDY DESIGN: Randomized controlled trial. Recruited women were randomized into two groups: GnRH antagonist and control group. The primary outcomes were incidence of premature LH surge and clinical pregnancy rates. RESULTS: One hundred and forty-one consecutive women were included in the study, with 70 in the antagonist group and 71 in the control arm. The baseline clinical characteristics were similar in both groups. The incidence of premature LH surge and premature luteinization was lower in the antagonist group as compared to the control group (5% vs. 10.3%, P=0.45 and 5% vs. 13.8, P=0.31) but not statistically significant. The clinical pregnancy rates were lower in the antagonist group (2.8% vs. 10%, P=0.12), which was also not statistically significant. CONCLUSION: The addition of GnRH antagonist during controlled ovarian stimulation and intrauterine insemination cycles does not lead to improvement in clinical pregnancy rates.

My notes (saved in your browser only)

MeSH descriptors

Gonadotropin-Releasing Hormone Insemination, Artificial Ovulation Induction Adult Female Gonadotropin-Releasing Hormone Humans Pregnancy Pregnancy Rate Young Adult

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (27)

Source provenance

openalex
last seen: 2026-05-14T06:03:08.038466+00:00
pubmed
last seen: 2026-10-08T21:10:53.858194+00:00
unpaywall
last seen: 2026-10-12T06:33:14.382917+00:00
License: CC0 · commercial use OK